SCHEMBL8528517

SCHEMBL8528517

O=C1Nc2ccc(OP(=O)(O)O)cc2C1=Cc1ccnc2ccccc12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TLK2 Q86UE8 4/20 0.42
MDM2 Q00987 7/20 0.41
CHEK1 O14757 1/20 0.41
RET P07949 2/20 0.40
TDP1 Q9NUW8 1/20 0.40
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
PDPK1 O15530 1/20 0.39
NTRK1 P04629 2/20 0.38
FLT3 P36888 2/20 0.38
PRKD3 O94806 1/20 0.38
ABL1 P00519 1/20 0.38
PDGFRB P09619 1/20 0.38
LTK P29376 1/20 0.38
KDR P35968 1/20 0.38
MAP2K2 P36507 1/20 0.38
CSNK1A1 P48729 1/20 0.38
CDK8 P49336 1/20 0.38
CDK7 P50613 1/20 0.38
MAP2K1 Q02750 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8526481 0.82 TLK2 (0.43) TLK2MDM2CHEK1RETTDP1
SCHEMBL8529758 0.82 PDPK1 (0.52) CHEK1RETTDP1MEN1KMT2A
SCHEMBL8528465 0.81 DHFR (0.42) TLK2MDM2CHEK1RETPDPK1
SCHEMBL7547880 0.80 CHEK1 (0.64) TLK2CHEK1RETKMT2APDPK1
SCHEMBL7131127 0.80 NTRK1 (0.47) CHEK1RETTDP1MEN1KMT2A
SCHEMBL8508649 0.80 RPS6KA3 (0.54) CHEK1RETTDP1MEN1KMT2A
SCHEMBL8584419 0.80 NTRK1 (0.63) TLK2CHEK1RETPDPK1NTRK1
SCHEMBL8584423 0.80 NTRK1 (0.63) TLK2CHEK1RETPDPK1NTRK1
SCHEMBL8530158 0.79 RET (0.45) CHEK1RETTDP1MEN1KMT2A
SCHEMBL8301615 0.79 TLK2 (0.58) TLK2MEN1KMT2APDPK1PDGFRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5840745-A INHIBITING CELL PROLIFERATION, TUMOR GROWTH, METASTASIS, DEVELOPMENT OF ATHEROMATOUS PLAQUE AND RESTENOSIS, CONTROLLING ANGIOGENESIS, TREATING DIABETES, ENHANCING CANCER THERAPY PHARMACIA S. P. A. (IT) 1998-11-24 US claimed
EP-0752985-A1 HYDROSOLUBLE 3-ARYLIDENE-2-OXINDOLE DERIVATIVES AS TYROSINE KINASE INHIBITORS PHARMACIA & UPJOHN S.p.A. (IT) 1997-01-15 EP claimed
WO-1996022976-A1 HYDROSOLUBLE 3-ARYLIDENE-2-OXINDOLE DERIVATIVES AS TYROSINE KINASE INHIBITORS PHARMACIA S.P.A. (IT) 1996-08-01 WO claimed
US-5840745-A INHIBITING CELL PROLIFERATION, TUMOR GROWTH, METASTASIS, DEVELOPMENT OF ATHEROMATOUS PLAQUE AND RESTENOSIS, CONTROLLING ANGIOGENESIS, TREATING DIABETES, ENHANCING CANCER THERAPY PHARMACIA S. P. A. (IT) 1998-11-24 US disclosed
EP-0752985-A1 HYDROSOLUBLE 3-ARYLIDENE-2-OXINDOLE DERIVATIVES AS TYROSINE KINASE INHIBITORS PHARMACIA & UPJOHN S.p.A. (IT) 1997-01-15 EP disclosed
WO-1996022976-A1 HYDROSOLUBLE 3-ARYLIDENE-2-OXINDOLE DERIVATIVES AS TYROSINE KINASE INHIBITORS PHARMACIA S.P.A. (IT) 1996-08-01 WO disclosed